{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:26:33Z","timestamp":1757611593206,"version":"3.44.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.canrad.2025.104687","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:18:47Z","timestamp":1754497127000},"page":"104687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recommandations de l\u2019Association francophone pour les soins oncologiques de support et de la Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique relatives aux effets secondaires respiratoires radio-induits"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2944-633X","authenticated-orcid":false,"given":"Olivier","family":"Crav\u00e9reau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Bourbonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efg","family":"Vaugier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Le Tinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Duchemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Habert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Martz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Gehin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bruand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Marcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Trampetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Cl\u00e9ment-Duch\u00eane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Lerouge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien","family":"Laville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Pourel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Zaccariotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Belli\u00e8re-Calendry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Thillays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9tienne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Godbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaad","family":"Nakad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautier","family":"Treffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00ebl","family":"Massin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Charzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canrad.2025.104687_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.canrad.2017.03.004","article-title":"[Medical prevention and treatment of radiation-induced pulmonary complications]","volume":"21","author":"Vallard","year":"2017","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1053-4296(03)00034-1","article-title":"Radiation-induced lung injury","volume":"13","author":"Marks","year":"2003","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semradonc.2010.01.010","article-title":"Radiation pulmonary toxicity: from mechanisms to management","volume":"20","author":"Graves","year":"2010","journal-title":"Semin Radiat Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104687_bib0020","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4187\/respcare.07150","article-title":"Post-breast cancer radiotherapy bronchiolitis obliterans organizing pneumonia","volume":"65","author":"Epler","year":"2020","journal-title":"Respir Care"},{"issue":"19","key":"10.1016\/j.canrad.2025.104687_bib0025","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/cancers14194642","article-title":"Radiation recall pneumonitis: a rare syndrome that should be recognized","volume":"14","author":"Jan","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2023.10.044","article-title":"Predicting radiation-induced lung injury in patients with lung cancer: challenges and opportunities","volume":"118","author":"Kuipers","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijrobp.2006.12.031","article-title":"Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"68","author":"Yom","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.03.041","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung","volume":"85","author":"Baker","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2025.104687_bib0045","doi-asserted-by":"crossref","first-page":"104323","DOI":"10.1016\/j.critrevonc.2024.104323","article-title":"Impact of smoking cessation duration on lung cancer mortality: a systematic review and meta-analysis","volume":"196","author":"Lai","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"De Ruysscher","year":"2019","journal-title":"Nat Rev Dis Primer"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0055","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12967-023-04212-5","article-title":"Re-evaluating the risk factors for radiation pneumonitis in the era of immunotherapy","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0060","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.cllc.2017.09.001","article-title":"Subjective Global Assessment (SGA) score could be a predictive factor for radiation pneumonitis in lung cancer patients with normal pulmonary function treated by intensity-modulated radiation therapy and concurrent chemotherapy","volume":"19","author":"Ma","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.radonc.2008.09.009","article-title":"Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy","volume":"91","author":"Jin","year":"2009","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/0973-1482.119339","article-title":"Acute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer: clinical, dosimetric, and associated-treatment risk factors","volume":"9","author":"Leprieur","year":"2013","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis","volume":"85","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2025.104687_bib0080","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.07.044","article-title":"Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer","volume":"82","author":"Yuan","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-018-1016-z","article-title":"The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation","volume":"13","author":"Ren","year":"2018","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.canrad.2021.08.007","article-title":"Guidelines for external radiotherapy and brachytherapy procedures: 3rd edition","volume":"26","author":"Giraud","year":"2022","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0095","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.lungcan.2013.10.001","article-title":"Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70Gy daily radiotherapy: CALGB 30904","volume":"82","author":"Salama","year":"2013","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617\u00a0randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104687_bib0105","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","article-title":"Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88\u00a0studies","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.canrad.2025.104687_bib0110","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamaoncol.2024.1841","article-title":"Long-term prospective outcomes of intensity modulated radiotherapy for locally advanced lung cancer: a secondary analysis of a randomized clinical trial","volume":"10","author":"Chun","year":"2024","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104687_bib0115","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s11136-018-1834-3","article-title":"Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study","volume":"27","author":"Yue","year":"2018","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.canrad.2025.104687_bib0120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/RTI.0000000000000293","article-title":"Lung cancer: posttreatment imaging: radiation therapy and imaging findings","volume":"32","author":"Benveniste","year":"2017","journal-title":"J Thorac Imaging"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-020-01376-4","article-title":"Radiation-induced lung injury: current evidence","volume":"21","author":"Arroyo-Hern\u00e1ndez","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13014-020-01654-9","article-title":"Radiation-induced lung toxicity\u00a0\u2013\u00a0cellular and molecular mechanisms of pathogenesis, management, and literature review","volume":"15","author":"K\u00e4smann","year":"2020","journal-title":"Radiat Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104687_bib0135","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.diii.2016.06.019","article-title":"Imaging after radiation therapy of thoracic tumors","volume":"97","author":"Ghaye","year":"2016","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccm.2016.12.004","article-title":"Radiation pneumonitis","volume":"38","author":"Bledsoe","year":"2017","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2004.11.029","article-title":"Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival","volume":"62","author":"Borst","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2\u00a0Suppl.\u00a03","key":"10.1016\/j.canrad.2025.104687_bib0150","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1053\/j.seminoncol.2005.03.010","article-title":"Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies","volume":"32","author":"Gopal","year":"2005","journal-title":"Semin Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104687_bib0155","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7326\/0003-4819-118-9-199305010-00006","article-title":"Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction","volume":"118","author":"Roberts","year":"1993","journal-title":"Ann Intern Med"},{"year":"2017","series-title":"Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0.","key":"10.1016\/j.canrad.2025.104687_bib0160"},{"issue":"7","key":"10.1016\/j.canrad.2025.104687_bib0165","doi-asserted-by":"crossref","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","article-title":"Prevention and treatment of cancer-related infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Baden","year":"2016","journal-title":"J Natl Compr Cancer Netw"},{"issue":"4","key":"10.1016\/j.canrad.2025.104687_bib0170","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ijrobp.2006.01.051","article-title":"Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis","volume":"65","author":"Kong","year":"2006","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","article-title":"Radiation-induced lung injury: assessment and management","volume":"156","author":"Hanania","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.canrad.2025.104687_bib0180","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1148\/rg.244035160","article-title":"Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis","volume":"24","author":"Choi","year":"2004","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0185","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tranon.2018.09.009","article-title":"Advances in molecular mechanisms and treatment of radiation-induced pulmonary fibrosis","volume":"12","author":"Chen","year":"2019","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0272-5231(03)00126-6","article-title":"Pulmonary complications of radiation therapy","volume":"25","author":"Abratt","year":"2004","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.canrad.2025.104687_bib0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2021.01.001","article-title":"Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer","volume":"157","author":"Cousin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104687_bib0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1748-717X-6-24","article-title":"Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer","volume":"6","author":"Ding","year":"2011","journal-title":"Radiat Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2025.104687_bib0205","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3109\/0284186X.2012.718093","article-title":"A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis","volume":"51","author":"Vogelius","year":"2012","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1179\/1973947815Y.0000000029","article-title":"Paclitaxel-induced pneumonitis in patients with breast cancer: case series and review of the literature","volume":"29","author":"Bielopolski","year":"2017","journal-title":"J Chemother"},{"issue":"4","key":"10.1016\/j.canrad.2025.104687_bib0215","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/annonc\/mdx009","article-title":"Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial","volume":"28","author":"Liang","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2025.104687_bib0220","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1748-717X-9-172","article-title":"Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy","volume":"9","author":"Dang","year":"2014","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/COC.0b013e3181d6b40f","article-title":"Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer","volume":"34","author":"Parashar","year":"2011","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104687_bib0230","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.ijrobp.2011.01.056","volume":"81","author":"Salama","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s13014-019-1440-8","article-title":"Risk factors of grade\u22652\u00a0radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer","volume":"14","author":"Sheng","year":"2019","journal-title":"Radiat Oncol"},{"issue":"13","key":"10.1016\/j.canrad.2025.104687_bib0240","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnci\/88.13.918","article-title":"Radiotherapy-related lung fibrosis enhanced by tamoxifen","volume":"88","author":"Bentzen","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00066-022-02032-y","article-title":"Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy","volume":"199","author":"Mangesius","year":"2023","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104687_bib0250","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/1759-7714.13816","article-title":"Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer","volume":"12","author":"Xu","year":"2021","journal-title":"Thorac Cancer"},{"issue":"7","key":"10.1016\/j.canrad.2025.104687_bib0255","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2402614","article-title":"Osimertinib after chemoradiotherapy in stage III EGFR-mutated NSCLC","volume":"391","author":"Lu","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.canrad.2025.104687_bib0260","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1200\/JCO.2011.38.4552","article-title":"Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer","volume":"30","author":"Lind","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0265","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC\u2013ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbcan.2019.02.004","article-title":"Rethinking pulmonary toxicity in advanced non-small cell lung cancer in the era of combining anti-PD-1\/PD-L1\u00a0therapy with thoracic radiotherapy","volume":"1871","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.canrad.2025.104687_bib0275","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fonc.2020.00561","article-title":"Radiation recall pneumonitis induced by anti-PD-1\u00a0blockade: a case report and review of the literature","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104687_bib0280","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ijrobp.2023.01.006","article-title":"Dose-limiting pulmonary toxicity in a phase 1\/2\u00a0study of radiation and chemotherapy with ipilimumab followed by nivolumab for patients with stage 3\u00a0unresectable non-small cell lung cancer","volume":"116","author":"Liveringhouse","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl.\u00a03","key":"10.1016\/j.canrad.2025.104687_bib0285","doi-asserted-by":"crossref","first-page":"102986","DOI":"10.1016\/j.esmoop.2024.102986","article-title":"Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III NSCLC: final results from PACIFIC-2","volume":"9","author":"Bradley","year":"2024","journal-title":"ESMO Open"},{"issue":"20","key":"10.1016\/j.canrad.2025.104687_bib0290","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.canrad.2025.104687_bib0295","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1002\/cam4.3113","article-title":"Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab","volume":"9","author":"Shaverdian","year":"2020","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.canrad.2025.104687_bib0300","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cllc.2021.01.017","article-title":"Incidence and risk factors of symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy and consolidation durvalumab","volume":"22","author":"Shintani","year":"2021","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0305","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10637-020-01060-8","article-title":"Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1\u00a0radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study","volume":"39","author":"Sugimoto","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.canrad.2025.104687_bib0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.lungcan.2022.07.005","article-title":"Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1\u00a0radiation pneumonitis","volume":"171","author":"Sugimoto","year":"2022","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0315","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jtho.2022.10.003","article-title":"Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from the PACIFIC-R study","volume":"18","author":"Girard","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2025.104687_bib0320","doi-asserted-by":"crossref","first-page":"110147","DOI":"10.1016\/j.radonc.2024.110147","article-title":"Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer","volume":"194","author":"Smesseim","year":"2024","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104687_bib0325","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104687_bib0330","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4329\/wjr.v6.i9.708","article-title":"Radiation pneumonitis after stereotactic radiation therapy for lung cancer","volume":"6","author":"Yamashita","year":"2014","journal-title":"World J Radiol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0335","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2020.01.009","article-title":"Validation of RTOG 0813\u00a0proximal bronchial tree constraints for pulmonary toxicity with stereotactic body radiation therapy for central non-small cell lung cancer","volume":"107","author":"Manyam","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104687_bib0340","doi-asserted-by":"crossref","first-page":"107281","DOI":"10.1016\/j.lungcan.2023.107281","article-title":"Stereotactic body radiotherapy for ultra-central lung tumors: a systematic review and meta-analysis and International Stereotactic Radiosurgery Society practice guidelines","volume":"182","author":"Yan","year":"2023","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.canrad.2025.104687_bib0345","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jtho.2018.02.023","article-title":"Brief report on radiological changes following stereotactic ablative radiotherapy (SABR) for early-stage lung tumors: a pictorial essay","volume":"13","author":"Ronden","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.canrad.2025.104687_bib0350","doi-asserted-by":"crossref","first-page":"107848","DOI":"10.1016\/j.lungcan.2024.107848","article-title":"Evaluation of chest CT-scans following lung stereotactic ablative radiotherapy: challenges and new insights","volume":"193","author":"De Bruycker","year":"2024","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.canrad.2025.104687_bib0355","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.21873\/anticanres.11141","article-title":"Radiation pneumonitis changes over time after stereotactic body radiation therapy for lung tumors: post-treatment cavity (sunny-side-up egg-like) changes","volume":"36","author":"Maebayashi","year":"2016","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.canrad.2025.104687_bib0360","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.prro.2017.10.008","article-title":"Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: findings of an International Delphi consensus study","volume":"8","author":"Nguyen","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0365","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2011.12.018","article-title":"Radiographic changes after lung stereotactic ablative radiotherapy (SABR)\u00a0\u2013\u00a0can we distinguish recurrence from fibrosis? A systematic review of the literature","volume":"102","author":"Huang","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0370","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2013.08.035","article-title":"Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients","volume":"109","author":"Nalbantov","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104687_bib0375","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3389\/fonc.2019.01511","article-title":"Left ventricular systolic dysfunction is a possible independent risk factor of radiation pneumonitis in locally advanced lung cancer patients","volume":"9","author":"Cai","year":"2019","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104687_bib0380","first-page":"e333","article-title":"2022\u00a0ESC Guidelines on cardio-oncology developed in collabration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0385","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12931-018-0775-2","article-title":"Abnormal pulmonary function tests predict the development of radiation-induced pneumonitis in advanced non-small cell lung Cancer","volume":"19","author":"Torre-Bouscoulet","year":"2018","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.canrad.2025.104687_bib0390","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1186\/s12885-023-11520-y","article-title":"Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease","volume":"23","author":"Kim","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.canrad.2025.104687_bib0395","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.canrad.2025.104687_bib0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaoncol.2023.7269","article-title":"Stereotactic radiation therapy in early non-small cell lung cancer and interstitial lung disease: a nonrandomized clinical trial","volume":"10","author":"Palma","year":"2024","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104687_bib0405","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijrobp.2017.03.010","article-title":"Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review","volume":"98","author":"Chen","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2025.104687_bib0410","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtho.2020.02.005","article-title":"A primer on interstitial lung disease and thoracic radiation","volume":"15","author":"Goodman","year":"2020","journal-title":"J Thorac Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:41:32Z","timestamp":1756932092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":82,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1278321825001039"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104687","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations de l\u2019Association francophone pour les soins oncologiques de support et de la Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique relatives aux effets secondaires respiratoires radio-induits","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104687"}}